—Տ°y‘fŠw‚̐i•ΰ|ŒŒ΄y‘fˆΩνΗ‚Φ‚ΜƒAƒvƒ[ƒ`(5)

CK Œ‡‘ΉΗ

ŽR@“Ή@@@G*1@‘ε@μ@“ρ@˜N*2
@@@@@@@@@@@@@@@@@@@@@@
Human Creatine Kinase Deficiency

Hiroshi YAMAMICHI, MT*1 and Jiro OHKAWA, MD*2

We describe a 56-year-old woman hospitalized under a diagnosis of acute myocardial infarction without an increase in serum creatine kinase(CK) activity during the clinical course. The patient had had no previous muscular symptoms. CK-M protein in the myocardial tissue of the patient was substantially lower(103}7ng/mg protein) than that in control myocardial tissue(35800}2860ng/mg protein). Immunoreactive CK-M in the patient tissue sample was 0.3% of the value for the control sample. CK-M mRNA was 53-fold less in the patient sample compared with the control. This very low expression of CK-M mRNA was considered to be the primary reason for CK-M deficiency. Direct sequencing demonstrated a point mutation at residue 54 in exon2, which was specific for the patient.
There were no other abnormalities found in the CK-M gene of the patient. This report identifies a molecular abnormality in human CK deficiency and discusses the physiologic relevance of CK-M.
[Rinsho Byori 50 : 576`583, 2002]

*1Clinical Laboratory Medicine, West Kobe Medical Center, Kobe 651-2273

yKey WordszCK isoenzyme(CK ƒAƒCƒ\ƒGƒ“ƒUƒCƒ€)Cgenetic(ˆβ“`)CCK-M deficiency(CK-M Œ‡‘Ή)Ca point mutation(“_“Λ‘R•ΟˆΩ)CmRNA suppression(mRNA —}§)

*1Ό_ŒΛˆγ—ΓƒZƒ“ƒ^[—Տ°ŒŸΈ‹Zp•”ˆγŽt‰οƒZƒ“ƒ^[(§651-2273 _ŒΛŽsΌ‹ζβο‘δ5-7-1)
*2•ΊŒΙŒ§—§¬l•aƒZƒ“ƒ^[ŒŸΈ•”(§673-8558 –ΎΞŽs–k‰€Žq’¬13-70)